Medplus Health Services Subsidiary Faces Income Tax Review Petition on ₹43.45 Crore Dispute
Medplus Health Services' subsidiary, Optival Health Solutions, is involved in a tax dispute of ₹43.45 Crores for AY 2020-21. The Income Tax Department filed a review petition on December 23, 2025, against a Telangana High Court order favorable to the subsidiary. The company received intimation on January 07, 2026.
The litigation involves a significant tax amount of ₹43.45 Crores, which could potentially impact the company's financials if the review petition is decided against them. However, the initial court order was favorable, mitigating immediate high impact.
The company received a favorable order, but the Income Tax Department has filed a review petition, creating uncertainty. The net sentiment remains neutral as the outcome is still pending.
MedPlus Health Services Limited has provided an update regarding a tax litigation involving its subsidiary, Optival Health Solutions Private Limited. The Income Tax Department has filed a review petition on December 23, 2025, against a favorable order received by Optival Health Solutions from the Hon’ble High Court of Telangana on November 21, 2025.
The original dispute pertained to an Assessment Order for AY 2020-21, with a disputed tax amount of ₹43.45 Crores. The company had filed a writ petition with the Telangana High Court, which was allowed in their favor. At that time, there was no expected financial impact on the company.
The company received intimation for the filing of the review petition on January 07, 2026. This update follows earlier letters dated August 28, 2023, and December 11, 2025. The details of this matter will be made available on the company's website and the websites of BSE and NSE.
What to do with a filing like this
Medplus Health Services Limited filed this with the NSE as a statutory disclosure, categorised under litigation updates. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Medplus Health Services Limited. Read the original for the full detail.